v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue (note 12) $ 2,483 $ 2,211 $ 7,820 $ 4,832
Cost of sales 536 593 2,041 1,361
Gross profit 1,947 1,618 5,779 3,471
Operating expenses        
Research and development 5,654 6,098 10,916 10,906
Selling, general and administrative 7,359 9,326 13,950 17,537
Total operating expenses 13,013 15,424 24,866 28,443
Operating loss 11,066 13,806 19,087 24,972
Other (income) expenses        
Net finance income (336) (343) (713) (788)
Net foreign exchange (gain) loss (1,245) 2,168 (1,861) 2,130
Total other (income) expenses (1,581) 1,825 (2,574) 1,342
Net loss before income taxes 9,485 15,631 16,513 26,314
Income tax expense 68 78 95 119
Deferred tax recovery (13) (14) (15) (14)
Total income tax expense 55 64 80 105
Net loss attributed to shareholders for the period 9,540 15,695 16,593 26,419
Item that may be reclassified to (income) loss        
Foreign currency translation adjustment 950 (2,713) 1,955 (2,816)
Net loss and other comprehensive loss for the period $ 10,490 $ 12,982 $ 18,548 $ 23,603
Loss per share (note 13)        
Basic net loss per common share (in dollars per share) $ 0.26 $ 0.52 $ 0.46 $ 0.88
Diluted net loss per common share (in dollars per share) $ 0.26 $ 0.52 $ 0.46 $ 0.88
Basic weighted average common shares outstanding (in shares) 36,350,665 30,053,142 36,324,393 30,055,047
Diluted weighted average common shares outstanding (in shares) 36,350,665 30,053,142 36,324,393 30,055,047
Recurring - non-capital        
Revenue (note 12) $ 1,612 $ 1,561 $ 4,086 $ 3,362
Capital equipment        
Revenue (note 12) $ 871 $ 650 $ 3,734 $ 1,470